GEFA: Early Fusion Approach in Drug-Target Affinity Prediction

• URL: http://arxiv.org/abs/2009.12146v2
• Date: Mon, 28 Sep 2020 01:47:49 GMT
• Title: GEFA: Early Fusion Approach in Drug-Target Affinity Prediction
• Authors: Tri Minh Nguyen, Thin Nguyen, Thao Minh Le, Truyen Tran
• Abstract summary: We propose a novel graph-in-graph neural network with attention mechanism to address the changes in target representation because of the binding effects. A drug is modeled as a graph of atoms, which then serves as a node in a larger graph of residues-drug complex. We also use pre-trained protein representation powered by the recent effort of learning contextualized protein representation.
• Score: 28.695523040015164
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Predicting the interaction between a compound and a target is crucial for rapid drug repurposing. Deep learning has been successfully applied in drug-target affinity (DTA) problem. However, previous deep learning-based methods ignore modeling the direct interactions between drug and protein residues. This would lead to inaccurate learning of target representation which may change due to the drug binding effects. In addition, previous DTA methods learn protein representation solely based on a small number of protein sequences in DTA datasets while neglecting the use of proteins outside of the DTA datasets. We propose GEFA (Graph Early Fusion Affinity), a novel graph-in-graph neural network with attention mechanism to address the changes in target representation because of the binding effects. Specifically, a drug is modeled as a graph of atoms, which then serves as a node in a larger graph of residues-drug complex. The resulting model is an expressive deep nested graph neural network. We also use pre-trained protein representation powered by the recent effort of learning contextualized protein representation. The experiments are conducted under different settings to evaluate scenarios such as novel drugs or targets. The results demonstrate the effectiveness of the pre-trained protein embedding and the advantages our GEFA in modeling the nested graph for drug-target interaction.

Related papers

• GramSeq-DTA: A grammar-based drug-target affinity prediction approach fusing gene expression information [1.2289361708127877]
  We propose GramSeq-DTA, which integrates chemical perturbation information with the structural information of drugs and targets. Our approach outperforms the current state-of-the-art DTA prediction models when validated on widely used DTA datasets.
  arXiv  Detail & Related papers  (2024-11-03T03:17:09Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• PGraphDTA: Improving Drug Target Interaction Prediction using Protein Language Models and Contact Maps [4.590060921188914]
  Key aspect of drug discovery involves identifying novel drug-target (DT) interactions. Protein-ligand interactions exhibit a continuum of binding strengths, known as binding affinity. We propose novel enhancements to enhance their performance.
  arXiv  Detail & Related papers  (2023-10-06T05:00:25Z)
• GraphCL-DTA: a graph contrastive learning with molecular semantics for drug-target binding affinity prediction [2.523552067304274]
  GraphCL-DTA is a graph contrastive learning framework for molecular graphs to learn drug representations. Next, we design a new loss function that can be directly used to adjust the uniformity of drug and target representations. The effectiveness of the above innovative elements is verified on two real datasets.
  arXiv  Detail & Related papers  (2023-07-18T06:01:37Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Resisting Graph Adversarial Attack via Cooperative Homophilous Augmentation [60.50994154879244]
  Recent studies show that Graph Neural Networks are vulnerable and easily fooled by small perturbations. In this work, we focus on the emerging but critical attack, namely, Graph Injection Attack. We propose a general defense framework CHAGNN against GIA through cooperative homophilous augmentation of graph data and model.
  arXiv  Detail & Related papers  (2022-11-15T11:44:31Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)
• GDGRU-DTA: Predicting Drug-Target Binding Affinity Based on GNN and Double GRU [0.0]
  We propose a novel method called GDGRU-DTA to predict the binding affinity between drugs and targets. Our model outperforms some state-of-the-art deep learning methods, and the results demonstrate the feasibility and excellent feature capture ability of our model.
  arXiv  Detail & Related papers  (2022-04-25T13:21:37Z)
• DrugOOD: Out-of-Distribution (OOD) Dataset Curator and Benchmark for AI-aided Drug Discovery -- A Focus on Affinity Prediction Problems with Noise Annotations [90.27736364704108]
  We present DrugOOD, a systematic OOD dataset curator and benchmark for AI-aided drug discovery. DrugOOD comes with an open-source Python package that fully automates benchmarking processes. We focus on one of the most crucial problems in AIDD: drug target binding affinity prediction.
  arXiv  Detail & Related papers  (2022-01-24T12:32:48Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)
• Bayesian neural network with pretrained protein embedding enhances prediction accuracy of drug-protein interaction [3.499870393443268]
  Deep learning approaches can predict drug-protein interactions without trial-and-error by humans. We propose two methods to construct a deep learning framework that exhibits superior performance with a small labeled dataset.
  arXiv  Detail & Related papers  (2020-12-15T10:24:34Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.